Health

Breakthroughs in Cancer Treatment

Updated 2026-08-20 10:40 UTC 1 source Positive

This year has seen significant progress in cancer treatment, with successful trials for both a pancreatic cancer drug and an mRNA neoantigen vaccine. However, Capricor Therapeutics faces potential FDA rejection for its Duchenne muscular dystrophy therapy.

Coverage timeline — 2 articles

STAT News

STAT+: One of the most consequential year for cancer treatment, ever

Between success with a pancreatic cancer drug and now success with an mRNA neoantigen vaccine, it has been a banner year for developing cancer therapies.

2026-08-20 10:30 UTC

STAT News

STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection

Capricor Therapeutics is trying to stave off FDA rejection of its cell therapy for Duchenne muscular dystrophy.

2026-08-20 10:30 UTC